1 / 3

Global Imatinib Drug Market, Size, Share, Analysis Report & Forecast to 2026

The global imatinib drug market is estimated to grow at a CAGR of around 4% during the forecast period.

alfahadkhan2510
Download Presentation

Global Imatinib Drug Market, Size, Share, Analysis Report & Forecast to 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Imatinib Drug Market, Size, Share, Analysis Report & Forecast to 2026 Global Imatinib Drug Market Size, Growth Analysis Report, Forecast to 2027 Global Imatinib Drug Market Size, Growth Analysis Report, Forecast to 2027 Global Imatinib Drug Market: Report Based on Development, Scope, Share, Trends, Forecast to 2027 Global Imatinib Drug Market Trends | Segmentation, Outlook, Industry Report to 2021-2027 The global imatinib drug market is estimated to grow at a CAGR of around 4% during the forecast period. The major factors contributing to the growth of the market include the rising prevalence of cancer and an increase in awareness programs towards cancer by government and private organizations. Imatinib is a chemotherapy drug that used to slow down or stopping the growth of the cancer cells. This medication is used for the treatment of certain types of cancer including, acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic syndrome. Imatinib drug helps in improving blood count which makes it highly effective and attracting the target patients for the adoption of this drug leading to the significant growth of the imatinib drug market. Free Sample Copy @ https://www.omrglobal.com/request-sample/imatinib-drug-market Geographically, the global imatinib drug market is segmented into North America, Europe, Asia- Pacific, and the Rest of the World. North America is expected to hold a major share in the market owing to the growing concern towards healthcare. According to the National Cancer Institute, in 2018, around 1,735,350 new cases of cancer are diagnosed in the US whereas

  2. around 600,000 died of cancer. The high prevalence of cancer is augmenting the growth of the imatinib drug market as leukemia is one of the most common cancers in the US. The presence of major companies in the region is propelling the growth of imatinib drug. These companies are significantly focusing on marketing their products across the globe and gain a competitive advantage. A Full Report of Global Imatinib Drug Market is Available at: https://www.omrglobal.com/industry-reports/imatinib-drug-market The global imatinib drug market is segmented based on drug form, and application. Based on drug form, the market is classified into tablets and capsules. Based on application the market is classified into blood cancer (leukemia and other blood cancers), gastrointestinal stromal tumors (GIST), skin tumors (dermatofibrosarcoma protuberans), and other tumors such as systemic mastocytosis. Blood cancer segment is expected to hold the major market share owing to increasing demand for imatinib for the treatment of different types of leukemia cancers such as Acute myeloid (or myelogenous) leukemia (AML), Chronic myeloid (or myelogenous) leukemia (CML), Acute lymphocytic (or lymphoblastic) leukemia (ALL), and Chronic lymphocytic leukemia (CLL). Global Imatinib Drug Market – Segmentation By Application •Food and Beverages •Chemical •Pharmaceutical •Others Global Imatinib Drug Market – Segmentation by Region North America •United States •Canada Europe •Germany •United Kingdom •France •Spain •Italy •Rest of Europe Asia-Pacific •China •Japan

  3. •India •Rest of Asia-Pacific Rest of the World Company Profiles •Apotex Inc. •Cipla, Inc. •Dr. Reddy’s Laboratory, Ltd. •Glenmark Pharmaceutical, Ltd. •Lupin, Ltd. •Mylan N.V. •Novartis AG •Sun Pharmaceutical Industries, Ltd. •Teva Pharmaceutical Industry, Ltd. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/imatinib-drug-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

More Related